We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.104
Bid: 0.10
Ask: 0.105
Change: -0.007 (-6.31%)
Spread: 0.005 (5.00%)
Open: 0.1075
High: 0.1075
Low: 0.10
Prev. Close: 0.111
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results

17 Jul 2019 07:00

RNS Number : 7513F
Versarien PLC
17 July 2019
 

17 July 2019

 

 

Versarien Plc

 

("Versarien" or the "Company" or the "Group")

 

Preliminary Results for the year ended 31 March 2019

 

Versarien Plc (AIM:VRS), the advanced engineering materials group, is pleased to announce its unaudited results for the year ended 31 March 2019.

 

 

Operational highlights

 

·

Thirteen new graphene application collaborations and MOU agreements secured during the year, with one entered into post period, with partners based in the UK and overseas

·

Versarien joined the Graphene Engineering Innovation Centre ("GEIC") as a tier one member gaining access to development and scale-up facilities worth c.£60 million

·

Continued investment in capital equipment as collaboration agreements progress

·

Acquisition of Gnanomat S.L. ("GNA"), a company based in Spain developing energy storage technology

·

Establishment of a US subsidiary, Versarien Graphene Inc., to exploit opportunities in North America

·

UK Government continues to support the Company's international expansion plans by seconding staff to Versarien, an 'Export Champion'

·

PolygreneTM launched, a new graphene enhanced polymer to improve thermal and electricity conductivity

·

Mature businesses showing steady financial performance providing stability for the emerging businesses

 

Financial highlights

 

·

Group revenues remained steady at £9.14 million (2018: £9.02 million)

·

Adjusted LBITDA* of £1.1 million (2018: £0.8 million)

·

Loss before tax of £2.8 million (2018: £1.6 million) after share based payments charge in the year of £0.7 million (2018: £0.1 million)

·

Cash at 31 March 2019 of £4.3 million (2018: £2.3 million)

·

Successful fundraising of £5.2 million gross in September 2018

·

Net assets increased by 66% to £13.3 million (2018: £8.0 million)

 

* Adjusted LBITDA (Loss before interest, tax, depreciation and amortisation) excludes exceptional items and share based payment charges.

 

 

Post Period Highlights

 

·

Versarien became the first company in the world to complete the US Graphene Council's 'Verified Graphene Producer' programme validating our technology to customers and collaborators

·

First graphene orders received from the USA and Japan

·

Term Sheet signed with the Beijing Institute of Graphene Technology ("BIGT") for China expansion

·

EU 'REACH' approval to produce up to 10 tonnes of graphene per annum received

·

Appointment of Susan Bowen as a Non-executive Director

 

 

Commenting on the results, Neill Ricketts, Chief Executive Officer of Versarien, said: "The year to 31 March 2019 has, again, been one of great progress for Versarien particularly in our emerging technologies businesses, globally and in the UK. The graphene businesses have delivered on our strategy of expansion into global markets and progress is being seen in our existing collaborations, as well as new collaborations being entered into. We look forward to showcasing our new technologies at future investor events.

 

"Having spent some time examining opportunities for expansion into China, the Board concluded that the best one lies with BIGT and consequently signed a term sheet with them in April 2019. A wholly owned foreign enterprise is being established and will be managed by BIGT on behalf of Versarien, with planned investment from a BIGT managed fund. BIGT will focus on both the manufacture and sale of our graphene in China using our patented technology. 

 

"Opportunities in South Korea, Japan and India are emerging as a result of the support given to us by the UK Government seconded staff and we have established operations in North America, albeit they are at an early stage.

 

"New graphene production equipment has been installed in the UK and is now up and running at our Cheltenham manufacturing site which will enable us to meet the initial expected demands of our graphene based products. Testing of new equipment is underway which, if successful, would expand our production capacity to up to 30 tonnes per annum of high quality graphene. Manufacture and sale of graphene at these levels requires certain permissions under EU regulations and I am pleased to report that we have been successful in our registration and are now accredited to produce significant volumes of graphene under the EU rules for chemical production.

 

"Our mature businesses have focussed on efficiency gains and overall have returned acceptable results whilst also looking at opportunities for inclusion of graphene in their future products. This includes using graphene in headphones and mobile phone cases, through to producing Hexotene enhanced ceramics for use in satellite engines.

 

"I would like to take this opportunity to thank our continually supportive investor base and our employees for their hard work as we look forward to the future with optimism and confidence."

 

 

For further information please contact:

 

Versarien Plc

www.versarien.com

Neill Ricketts - Chief Executive Officer

+44 (0) 1242 269122

Chris Leigh - Chief Financial Officer

 

 

 

 

 

Cannacord Genuity Group Inc (Nominated Adviser and Broker)

 

Bobbie Hilliam / Emma Gabriel

+44 (0)20 7523 8000

 

 

 

 

IFC Advisory (Financial PR and IR) 

www.investor-focus.co.uk

Tim Metcalfe / Graham Herring / Heather Armstrong

+44 (0) 20 3934 6630

 

 

Notes to Editors:

 

About Versarien

 

Versarien Plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has six subsidiaries operating under two divisions:

 

Graphene and Plastics

2-DTech Limited, which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

AAC Cyroma Limited, which specialises in the supply of vacuum-formed and injection-moulded products to the automotive, construction, utilities and retail industry sectors. Using Versarien's existing graphene manufacturing capabilities, AAC will have the ability to produce graphene-enhanced plastic products. www.aaccyroma.co.uk  

Cambridge Graphene Ltd, supplies novel inks based on graphene and related materials, using patented processes to develop graphene materials technology.

www.cambridgegraphene.com

Gnanomat S.L. ("GNA"), based in the Parque Cientifico Madrid, Spain, is a company capable of utilising Versarien's graphene products in an environmentally friendly, scalable production process for energy storage devices that offer high power density, fast recharging and long lifetime for use in electrical vehicles and portable electronics products. www.gnanomat.com

 

Hard Wear and Metallic Products

Versarien Technologies Limited has developed an additive process for creating advanced micro-porous metals targeting the thermal management industry and supplies extruded aluminium. www.versarien-technologies.co.uk 

Total Carbide Limited, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com 

 

 

Chief Executive's Statement

 

Versarien consists of two main business segments; Graphene and Plastic Products focussed on delivering graphene solutions through plastics and carbon fibre composites, and Hard Wear and Metallic Products focussed on delivering aluminium and tungsten carbide products.

 

Graphene and Plastic Products

 

The graphene businesses continue to make significant progress. We are very proud to be the first company in the world to receive independent verification from the US based Graphene Council that has declared our Nanene graphene nano-platelets meet their standards. Not only is this a confirmation of the quality of our product, but also provides us with a competitive advantage.

 

With the launch of PolygreneTM, we have again increased our range of graphene-based products, providing a polymer which can improve thermal and electrical conductivity.

 

The UK Government continues to provide support to Versarien with seconded staff and has also entered into partnership with us as an 'Export Champion'. This support enables us to increase our global presence and succeed in our global strategy. In China we now have many MOUs (multiple with Fortune 500 companies) which are project related across a multitude of sectors, with work either currently on-going or with preliminary discussions and testing taking place. In South Korea we have two collaboration agreements now in place and discussions with around 20 companies which are on-going and we are engaging with JETRO, a core government organisation for attracting inward investment in Japan. In India we are looking at opportunities for a joint venture arrangement with a suitable partner.

 

I am pleased to provide an update on our current commercial collaborations:

 

Date entered into

Description

Current status

October 2017

Collaboration with Israel Aerospace Industries

Development of applications continuing with multiple partners, including GEIC and Warwick Manufacturing Group ("WMG").

 

November 2017

Collaboration with Global Consumer Goods Company

Blow moulded bottle samples were successfully produced at customer facility. Samples currently being tested and assessed at customer facility and WMG. A new agreement has also been signed with a separate division of this company. The agreement will focus on the development of flexible packaging solutions and seek to utilise graphene properties in new and existing packaging.

 

December 2017

Agreement with Global Chemical Major

Masterbatch testing completed with notable improvements in puncture resistance. Further tests underway with Graphinks and Hexotene.

 

January 2018

Agreement with Global Apparel Manufacturer

First sample garments produced and independently tested to industry standards by a recognised UK based test house. The results show wide improvement in key areas when compared to a non-graphene garment. The key areas included abrasion resistance, moisture and air permeability, water vapour and thermal resistance, stretch, wicking and drying rate. A Second batch of garments is currently being produced and will go to other engagement partners for wearer trials.

 

February 2018

Medical Technology collaboration at Addenbrooke's hospital

Initial positive discussions have now been held with two leading global manufacturers of dressings and further multi-partner discussions will be held in the near future.

 

February 2018

Agreement with the shoemaker Vivobarefoot

Production relocation caused temporary delay to the project. Initial compounding of materials has now been successfully completed with different variations of materials and loadings. Further tests now underway and first samples to be produced. Commercial understanding over a launch product in place.

 

March 2018

Collaboration with Team Sky (now Team INEOS) for cycling equipment

 

Project held up due to change of sponsor. The parties will re-engage in September 2019.

March 2018

Collaboration with world leading aerospace group

Sample parts have been sent to us for initial evaluation.

 

April 2018

Agreement with Luxus

Active supply chain partner, who are working with us on various projects.

 

May 2018

Consumer goods collaboration for polymer structures in plastics

Initial testing at limited loadings showed a demonstrable improvement in potential use of plastics. Targets have now been set to achieve significant reductions in plastics use. Further development in bottle design and weight/percentage loadings has now commenced.

 

June 2018

Agreement with Arrow Green Tech

IP application submitted for initial water-soluble polymer. Engagement underway in India with multiple companies across various sectors.

 

June 2018

Commercial agreement with MediaDevil

First earphones launched into the market in December 2018, with next generation products now being designed. In addition, new accessories such as phone cases with graphene have now been tested, with launch dates currently being planned.

 

July 2018

Collaboration with ZapGo Ltd

Trials continue with different materials and loadings.

 

August-2018

Sporting goods collaboration

Initial trials of a new Polygrene mix show significant improvement in outer soles with further development now underway. In addition, work has commenced on a new design for another variation of football shoe. Confirmation that this partner will also feature in the wearer trials for the garments referred to in the update with the global apparel manufacturer.

 

August-2018

Collaboration with Axia Materials, South Korea

Consortium of companies exploring further funding opportunities and potential new partners.

August-2018

Construction materials collaboration with AECOM

Collaboration progressing well with additional collaboration agreement signed to investigate graphene enhanced concrete structures.

 

October-2018

Collaboration with Advanced Insulation

Testing underway at customer facility.

December 2018

Collaboration with Chinese Aerospace Company

Work plan created with involved multiple partners, including GEIC and WMG.

December 2018

MOU China Railway

Several projects are now underway including concrete projects which feature multiple partners, including GEIC.

December 2018

LOI/MOU Tungshu Optoelectronics

Our collaboration with Tungshu is continuing with a number of projects identified. These include flexible packaging, thermal interfaces for heat dissipation in electronics, thermoplastic components, various electrical devices and using graphene insole sensors in Tungshu's smart wearables.

 

March 2019

Further collaboration with Chinese Aerospace Company

Workplan created with involved multiple partners, including GEIC and WMG.

May 2019

Collaboration agreement with BP Polymers

 

Initial workflow plan agreed and being implemented.

 

 

 

The level of our graphene related sales is mainly dependent upon the rate at which our collaborations progress. The year under review has seen significant progress which is expected to validate our business model and provide future sales growth from the current minimal levels. Alongside the collaborations, we have seen an increase in interest following our Graphene Council verification with our first orders from partners in USA and Japan post period end.

 

During the year we have invested in new plant and equipment aimed at increasing annual production capacity to three tonnes of graphene and one tonne of Hexotene by the end of 2019. This should enable us to meet the expected demand for our high-quality graphene-based products.

 

We are now in discussions with many cities, provinces and companies in China, and have signed a Term Sheet with BIGT in April 2019. Final contracts have yet to be completed, so there cannot be certainty, but the intention is that other interested parties and regions will form tier two investment opportunities in joint ventures to be agreed.

Since its acquisition in October 2018, GNA has been awarded a patent by the Oficina Espanola de Patentes y Marcas, the Spanish patent office, covering a method of obtaining nanomaterials composed of carbonaceous material and metallic oxides. This has also been filed under the PCT regime.

GNA has also recruited a new Chief Technology Officer and successfully completed the testing of its pilot production plant. It has also entered into collaboration agreements with two supercapacitor manufacturers and is in dialogue with a further three global supercapacitor manufacturers, as well as participating in the European Battery Alliance.

AAC Cyroma, our plastics business, was principally a strategic purchase to allow us to incorporate graphene into plastic products as well as providing revenue and cash flow in its own right. Its revenues have remained stable and returned a reasonable result whilst working with the first mover collaborations, such as with Media Devil and its own customer base, with samples being provided for customer testing.

 

Hard Wear and Metallic Products

 

Our Hard Wear parts business has performed in line with the previous year and a recent review of operations has been conducted to improve operational efficiencies. It is particularly pleasing that it has seen an increase it its recent order books and is now involved in a project involving the use of Hexotene in ceramics. We have previously stated that the thermal/aluminum products business is non-core, but nonetheless recent restructuring has improved its business performance.

 

Key performance indicators

 

As a Group that consists of mature products supporting the development of early stage technology products, we concentrate on the following financial metrics:

 

 

2019

£'000

2018

£'000

Revenue

9,140

9,024

Gross margin percentage

27%

28%

Loss before interest, tax, depreciation, amortisation, exceptional costs and share based charges

(1,134)

(801)

Cash used by Graphene and Plastic Products

(1,305)

(1,090)

Cash used by Hard Wear and Metallic Products

(266)

(82)

Cash raised/(utilised) by parent (before loans to/from subsidiaries)

3,567

2,101

Net Cash raised and generated/(used) by the Group

1,996

929

 

Current trading and outlook

 

The Group has started the new financial year very positively, with pleasing levels of revenue and profit from its Plastics and Hard Wear and Metallic businesses. With the investment in operational efficiencies made in the year ended 31 March 2019, we anticipate a further positive impact to the results in the current financial year.

 

We have also seen progress in the US, with four new collaboration agreements having been recently entered into in North America, and were pleased to announce that we received our first order in June 2019 for 12kg of our graphene from a US based company, operating in the oil and gas exploration sector. We also look forward to working with potential new US based partners following the American Graphene Summit in May 2019, where Versarien was a leading participant.

 

We also look to the future with great excitement regarding our expansion into China, South Korea and Japan which could bring significant growth for the graphene businesses. We have already seen our first order from a North American corporate research and development centre of a Japanese headquartered company. This customer is a global automotive components company that has operations in over 40 countries, employing in excess of 250,000 people.

 

This current year we expect, with confidence, to see the benefits of the many achievements and progress that we have accomplished during the year ended 31 March 2019, and the continued trend of increased orders for our products.

 

Neill Ricketts

Chief Executive Officer

 

 

Financial Review

 

Versarien's revenue for the year ended 31 March 2019 was £9.1 million (2018: £9.0 million) with operating losses before exceptional costs, depreciation, amortisation and share based payment charges of £1.1 million (2018: £0.8 million).

 

Exceptional costs were £0.4 million (2018: £0.03 million) as a result of the Group's focus on global expansion and growth through acquisition. The loss before tax for the year was £2.8 million (2018: £1.6 million), after share based payment charges of £0.7 million in the year (2018: £0.1 million).

 

It is the Board's intention to continue to align shareholder and senior staff interests through the award of share options rather than just remuneration. IFRS 2 (share based payments) dictates the accounting treatment of such options using simulations such as Black Scholes or Monte Carlo to try and determine the fair value of such awards. These models contain many assumptions, but one which has a material impact on the valuation is share volatility. Versarien, in line with many other AIM quoted shares, has seen a high level of volatility since being admitted to AIM. The consequence of this is that such simulation models allow for large share price movements resulting in a high charge in the year of £0.7 million (2018: £0.1 million). This is a non-cash movement in the accounts and is simply an accounting transaction required under IFRS 2 to reflect the potential future value of the shares.

 

As part of the expansion of our graphene businesses in the UK and overseas, we have continued to invest heavily in them. We are confident, that whilst revenues of any material amount have yet to be achieved, with the investment that we have made, the accreditations awarded and progress of our collaborations this year, significant future revenues will be achieved. Adjusted LBITDA for the graphene businesses was £1.1 million (2018: £0.9 million). 

 

Our plastics business, AAC Cyroma has had a steady year, returning revenues of £4.7 million (2018: £4.6 million) and EBITDA of £0.2 million (2018: £0.4 million).

 

Our mature Hard Wear and Metallic businesses have provided stability to support the development of the emerging businesses, with Total Carbide returning revenues of £3.2 million (2018: £3.2million) and EBITDA of £0.5 million (2018: £0.5 million) and Versarien Technologies similarly returning revenues of £1.2 million (2018: £1.2 million) and adjusted LBITDA of £0.1 million (2018 £0.1 million).

 

Group net assets at 31 March 2019 were £13.3 million (2018: £8.0 million) following the acquisition of Gnanomat S.L. ("GNA"). The consideration for the acquisition was £2,647,000 settled by cash of £0.7 million, by way of GNA issuing new shares in its company to Versarien, and the issue of 1,316,278 new ordinary shares of 1 pence each in Versarien to existing GNA shareholders at an agreed price of 150 pence per share. In September 2018 the Group successfully raised £5.2 million before expenses, and at the year end the Group had cash of £4.3m (2018: £2.3 million), of which £0.6 million (2018: £1.1 million) had been drawn under the invoice finance facilities. As at period end the Company had £0.6 million of headroom in its invoice finance facilities (2018: £0.7 million). The Directors consider this sufficient for our current activities over the coming twelve months having made certain assumptions, further details of which are contained below.

 

Cash outflow from operating activities was £1.7 million (2018: £1.9 million). The Group invested £0.7 million, net of cash, in acquisitions (2018: £nil), £0.4 million (2018: £0.1 million) in capitalised development costs, and £0.5 million (2018: £0.3 million) in plant and machinery. 

 

Going concern

 

The financial statements, which are not yet approved, have been prepared on a going concern basis, which the Directors believe to be appropriate for the following reasons:

 

● The Group meets its day-to-day working capital requirements through careful cash management and the use of its invoice discounting facilities; and

● As at 31 March 2019, the Group had cash balances totalling £4.3 million with £0.6 million of headroom on its invoice discounting facilities.

 

The Directors have prepared detailed projections of expected future cash flows for a period of twelve months from the date of issue of this preliminary statement. These show that the Group is expected to have sufficient cash available to meet its obligations as they fall due for the foreseeable future (at least twelve months). These projections assume modest sales growth in the mature revenue generating businesses and the continued utilisation of the invoice finance facilities.

 

After due consideration, the Directors have concluded that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future (at least twelve months). For this reason, they continue to adopt the going concern basis in preparing the consolidated financial statements.

 

 

Chris Leigh

Chief Financial Officer

 

 

 

 

 

 

Group statement of comprehensive Income (unaudited)

Year ended 31 March 2019

 

Notes

2019

£'000

2018

£'000

Continuing operations

 

 

 

Revenue

2

9,140

9,024

Cost of sales

 

(6,706) 

(6,496)

Gross profit

 

2,434

2,528

Other operating income

 

148

63

Operating expenses (including exceptional items)

 

(5,345)

(4,102)

Loss from operations before exceptional items

 

(2,343)

(1,477)

Exceptional items

3

(420)

(34)

Loss from operations

 

(2,763)

(1,511)

Finance costs

 

(66)

(50)

Finance income

 

-

-

Loss before income tax

 

(2,829)

(1,561)

Income tax

 

117

63

Loss for the year

 

(2,712)

(1,498)

 

 

 

 

Loss attributable to:

 

 

 

- Owners of the parent company

 

(2,473)

(1,381)

- Non-controlling interest

 

(239)

(117)

 

 

(2,712)

(1,498)

 

 

 

 

Loss per share attributable to the equity holders of the Company:

 

 

 

 

 

 

 

Basic and diluted loss per share

5

(1.64)p

(1.00)p

 

There is no other comprehensive income for the year.

 

 

 

 

 

Group statement of financial position (unaudited)

As at 31 March 2019

 

 

 

Notes

2019

£'000

2018

£'000

Assets

 

 

 

Non-current assets

 

 

 

Intangible assets

6

5,318

2,678

Property, plant and equipment

7

3,170

2,980

Deferred taxation

 

25

25

 

 

8,513

5,683

Current assets

 

 

 

Inventory

 

2,253

1,961

Trade and other receivables

 

2,141

2,437

Current tax

 

106

77

Cash and cash equivalents

 

4,292

2,296

 

 

8,792

6,771

Total assets

 

17,305

12,454

Equity

 

 

 

Called up share capital

8

1,536

1,486

Share premium account

8

19,776

12,529

Merger reserve

 

1,256

1,256

Share-based payment reserve

 

899

187

Retained losses

 

(9,698)

(7,225)

Equity attributable to owners of the parent company

 

13,769

8,233

Non-controlling interest

 

(493)

(254)

Total equity

 

13,276

7,979

 

 

 

 

Liabilities

 

 

 

Non-current liabilities

 

 

 

Trade and other payables

 

328

167

Deferred tax

 

69

64

Long-term borrowings

 

708

456

 

 

1,105

687

Current liabilities

 

 

 

Trade and other payables

 

1,528

1,849

Provisions

 

174

80

Current tax

 

257

284

Invoice discounting advances

 

603

1,117

Current portion of long-term borrowings

 

362

458

 

 

2,924

3,788

Total liabilities

 

4,029

4,475

Total equity and liabilities

 

17,305

12,454

 

 

 

 

 

 

Group statement of changes in equity (unaudited)

Year ended 31 March 2019

 

 

Share

 capital

£'000

Share

premium

account

£'000

Merger

reserve

£'000

Share-based

payment

 reserve

£'000

Accumulated losses

£'000

 

Non-controlling

Interest

£'000

Total

equity

£'000

At 1 April 2017

1,313

9,762

1,256

115

(5,844)

(137)

6,465

Issue of shares

173

2,767

-

-

-

-

2,940

Loss for the year

-

-

-

-

(1,381)

(117)

(1,498)

Share-based payments

-

-

-

72

-

-

72

At 31 March 2018

1,486

12,529

1,256

187

(7,225)

(254)

7,979

Issue of shares

50

7,247

-

-

-

-

7,297

Loss for the year

-

-

-

-

(2,473)

(239)

(2,712)

Share-based payments

-

-

-

712

-

-

712

At 31 March 2019

1,536

19,776

1,256

899

(9,698)

(493)

13,276

 

 

 

 

 

Statement of Group cash flows (unaudited)

Year ended 31 March 2019

 

 

 

Notes

 

2019

£'000

 

2018

£'000

Cash flows from operating activities

 

 

 

Cash used in operations

9

(1,737)

(1,907)

Interest paid

 

(66)

(50)

Corporation Tax paid

 

-

(9)

Net cash used in operating activities

 

(1,803)

(1,966)

Cash flows from investing activities

 

 

 

Acquisition of subsidiaries (net of cash acquired)

 

(673)

-

Purchase of intangible assets

 

(434)

(148)

Purchase of property, plant and equipment

 

(541)

(280)

Net cash used in investing activities

 

(1,648)

(428)

Cash flows from financing activities

 

 

 

Share issue

 

5,155

3,069

Share issue costs

 

(200)

(129)

Finance leases (net of repayments)

 

156

1

Invoice discounting loan (repayments)/proceeds

 

(514)

382

Net cash generated from financing activities

 

4,597

3,323

Increase/(decrease) in cash and cash equivalents

 

1,146

929

Cash acquired on acquisition

 

850

-

Cash and cash equivalents at beginning of year

 

2,296

1,367

Cash and cash equivalents at end of year

 

4,292

2,296

 

 

 

 

Notes to the Financial Statements (unaudited)

1. Basis of preparation

The consolidated financial statements consolidate the results of the Company and its subsidiaries (together referred to as the "Group").

 

The financial information included in this preliminary announcement does not constitute statutory accounts of the Group for the years ended 31 March 2019 or 31 March 2018. The financial information for the year ended 31 March 2018 is derived from statutory accounts upon which the auditors have reported. Their report was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498(2) or (3) of the Companies Act 2006. The auditors work on the statutory accounts of the Group for the year ended 31 March 2019 is not yet complete.

 

Both the consolidated financial statements and the Company financial statements are prepared in accordance with International Financial Reporting Standards as adopted by the EU ("IFRS").

 

2. Segmental reporting

At 31 March 2019 the Group was organised into two business segments. Central costs are reported separately.

Information reported to the Group's Chief Executive Officer for the purposes of resource allocation and assessment of performance is focused on the two principal business segments of Graphene and Plastic Products and Hard Wear and Metallic Products and, accordingly, the Group's reportable segments under IFRS 8 are based on these activities.

Segment profit/(loss) represents the profit/(loss) earned by each segment, including a share of central administration costs, which are allocated on the basis of actual use or pro rata to sales. This is the measure reported to the Chief Executive Officer for the purposes of resource allocation and assessment of segment performance.

The segment analysis for the period ended 31 March 2019 is as follows:

 

Central

£'000

Graphene and Plastic

Products

£'000

 Hard Wear and Metallic

 Products

£'000

Intra-group

adjustments

£'000

Total

£'000

Revenue

-

4,729

4,416

(5)

9,140

Gross profit

-

1,064

1,370

-

2,434

Other operating income

-

144

4

-

148

Operating expenses

(1,430)

(2,582)

(1,274)

(59)

(5,345)

(Loss) from operations

(1,430)

(1,374)

100

(59)

(2,763)

Finance income/(charge)

3

(43)

(26)

-

(66)

(Loss)/profit before tax

(1,427)

(1,417)

74

(59)

(2,829)

Total assets

16,058

5,536

4,780

(9,069)

17,305

 Total liabilities

(1,107)

(6,963)

(4,068)

8,109

(4,029)

Net assets/(liabilities)

14,951

(1,427)

712

(960)

13,276

Capital expenditure

166

775

34

-

975

Depreciation/amortisation

13

245

207

32

497

 

 

 

The segment analysis for the period ended 31 March 2018 is as follows:

 

Central

£'000

Graphene and Plastic

Products

£'000

 

 Hard Wear

And Metallic Products

£'000

Intra-group

adjustments

£'000

Total

£'000

Revenue

-

4,643

4,385

(4)

9,024

Gross profit

-

1,198

1,330

-

2,528

Other operating income

-

9

54

-

63

Operating expenses

(695)

(1,918)

(1,437)

(52)

(4,102)

(Loss) from operations

(695)

(711)

(53)

(52)

(1,511)

Finance income/(charge)

-

(21)

(29)

-

(50)

(Loss) before tax

(695)

(732)

(82)

(52)

(1,561)

Total assets

9,264

4,575

4,911

(6,296)

12,454

Total liabilities

(897)

(5,358)

(4,345)

6,125

(4,475)

Net assets/(liabilities)

8,367

(783)

566

(171)

7,979

Capital expenditure

2

373

53

-

428

Depreciation/amortisation and impairment

5

227

511

52

795

 

Geographical information

The Group's revenue from external customers and information about its segment assets by geographical location are detailed below:

 

 

Revenue from external customers

 

Non-current assets

 

2019

£'000

2018

£'000

 

2019

£'000

2018

£'000

United Kingdom

7,577

7,657

 

6,203

5,683

Rest of Europe

1,065

1,002

 

2,310

-

North America

306

2

 

-

-

Other

192

363

 

-

-

 

9,140

9,024

 

8,513

5,683

 

 

3. Exceptional items

 

 

 

2019

£'000

2018

£'000

Relocation and restructuring costs

59

31

Costs relating to expansion in China

271

-

Costs relating to setting up of the US subsidiary

28

-

Acquisition costs

29

-

Release of deferred consideration

-

(80)

Impairment of development costs (note 6) net of deferred grant income release

-

72

Other

33

11

 

420

34

 

 

 

 

 

4. Dividends

As stated in the Company's AIM Admission Document, the Board will not be declaring or proposing any dividends until such time as the commercialisation of its product portfolio has generated sufficient distributable reserves from which to do so.

 

5. Loss per ordinary share

 

The calculation of the basic loss per share for the period ended 31 March 2019 and 31 March 2018 is based on the losses attributable to the shareholders of Versarien Plc divided by the weighted average number of shares in issue during the year. The calculation of diluted loss per share is based on the basic loss per share adjusted to allow for the issue of shares on the assumed conversion of all dilutive options. However, in accordance with IAS 33 "Earnings Per Share" potential ordinary shares are only considered dilutive when their conversion would decrease the profit per share or increase the loss per share. As at 31 March 2019 there were 14,985,100 (2018: 8,222,830) potential ordinary shares which have been disregarded in the calculation of diluted loss per share as they were considered non-dilutive at that date.

 

 

Loss

attributable to

shareholders

£'000

Weighted

average

number of

shares

£'000

Basic loss

per share

pence

Year ended 31 March 2019

(2,473)

151,129

(1.64)

Year ended 31 March 2018

(1,381)

138,208

(1.00)

 

 

6. Intangible assets

 

Goodwill

£'000

Other

intangibles

£'000

Total

£'000

Cost

 

 

 

At 1 April 2017

2,167

1,395

3,562

Additions

-

148

148

At 1 April 2018

2,167

1,543

3,710

Additions

-

434

434

Disposals

-

(21)

(21)

Acquisitions

2,264

20

2,284

At 31 March 2019

4,431

1,976

6,407

Accumulated amortisation and impairment

 

 

 

At 1 April 2017

-

639

639

Impairment

 

191

191

Amortisation charge

-

202

202

At 1 April 2018

-

1,032

1,032

Disposals

 

(13)

(13)

Amortisation charge

-

70

70

At 31 March 2019

-

1,089

1,089

Carrying value

 

 

 

At 31 March 2019

4,431

887

5,318

At 31 March 2018

2,167

511

2,678

 

The impairment of Other Intangibles in 2018 relates to development costs in Versarien Technologies Limited as per exceptional items, note 3.

 

 

 

 

 

Other intangible assets

 

31 March 2019

£'000

31 March 2018

£'000

Customer relationships/order books

81

113

Development costs

600

235

Licence

48

33

Intellectual property

158

130

Total

887

511

 

 

 

 

 

 

 

 

 

 

 

 

 

7. Property, plant and equipment

Group

Plant and

equipment

£'000

Leasehold

improvements

£'000

Total

£'000

Cost

 

 

 

At 1 April 2017

9,024

488

9,512

Additions

250

30

280

Disposals

(27)

-

(27)

At 1 April 2018

9,247

518

9,765

Additions

541

-

541

Acquisitions

76

-

76

Disposals

(2)

-

(2)

At 31 March 2019

9,862

518

10,380

Accumulated depreciation

 

 

 

At 1 April 2017

6,386

20

6,406

Charge for the year

372

30

402

Disposals

(23)

-

(23)

At 1 April 2018

6,735

50

6,785

Charge for the year

393

34

427

Disposals

(2)

-

(2)

At 31 March 2019

7,126

84

7,210

Net book value

 

 

 

At 31 March 2019

2,736

434

3,170

At 31 March 2018

2,512

468

2,980

 

 

Plant and equipment include the following amounts where the Group is a lessee under finance leases and hire purchase contracts:

 

 

Group

2019

£'000

Group

2018

£'000

Cost

4,453

3,889

Accumulated depreciation

(2,567)

(2,326)

Net book value

1,886

1,563

 

 

 

 

8. Called up share capital and share premium

 

 

Number

of shares

'000

Ordinary

shares

£'000

Share

premium

£'000

Total

£'000

At 1 April 2017

131,331

1,313

9,762

11,075

Issue of shares

17,334

173

2,767

2,940

At 31 March 2018

148,665

1,486

12,529

14,015

Issue of shares

4,959

50

7,247

7,297

At 31 March 2019

153,624

1,536

19,776

21,312

 

 

9. Cash used in operations

 

 

 

2019

£'000

2018

£'000

 

Loss before tax

(2,829)

(1,561)

 

Adjustments for:

 

 

 

Share-based payments

712

72

 

Depreciation

427

402

 

Amortisation

70

202

 

Impairment

-

191

 

Disposal of non-current assets

8

4

 

R&D tax credit repayment

117

72

 

Finance cost

66

50

 

Decrease/(increase) in trade and other receivables

424

(569)

 

Increase in inventories

(292)

(73)

 

Decrease in trade and other payables

(440)

(697)

 

Cash flows from operating activities 

(1,737)

(1,907)

 

 

 

10. Report and accounts

 

Copies of the 2019 Annual Report and Accounts will be posted to shareholders in due course once they are finalised and approved. Further copies may be obtained by contacting the Company Secretary at the registered office. In addition, the 2019 Annual Report and Accounts will be available to download from the investor relations section on the Company's website www.versarien.com.

 

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR SFAFWMFUSESW
Date   Source Headline
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.